Requests that the FDA update Section 11 Descriptions of the Full Prescribing Information to be updated to include all active ingredients in Premarin tablets. | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-8330

Requests that the FDA update Section 11 Descriptions of the Full Prescribing Information to be updated to include all active ingredients in Premarin tablets.

Documents

Comments

Key Dates

Comment Period OpensJul 29, 2026

Documents

Type	Title	Posted	Comments	Status
Supporting Material	Attachment 1	Jul 29, 2026	--

Keywords

Citizen Petition

Diamond Research Foundation

update Section 11 Descriptions

of the Full Prescribing Information

to be updated to include

all active ingredients in Premarin tablets

OPEN

Data from Regulations.gov